Celsius Holdings Inc
CELH
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
211.4% upsideUndervalued by 211.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.51 Billion |
|---|---|
| Enterprise Value | $10.48 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.25 |
| Beta | 0.94 |
| Outstanding Shares | 257,012,000 |
Return
| Return on Equity | 10.77% |
|---|---|
| Return on Assets | 2.61% |
| Return on Invested Capital | 5.78% |
Valuation & Multiples
| P/E Ratio | 49.23 |
|---|---|
| PEG | 53.78 |
| Price to Sales | 2.73 |
| Price to Book Ratio | 7.5 |
| Enterprise Value to Revenue | 3.53 |
| Enterprise Value to EBIT | 44.19 |
| Enterprise Value to Net Income | 77 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 2.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5795▼ 11.00% |
|---|---|
| Total Calls | 12,898,300▼ 31.15% |
| Total Puts | 7,474,600▼ 42.14% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.07%▼ 2.04% |
|---|---|
| Total Invested | $5.79B▼ 22.14% |
| Investors Holding | 625▼ 41.00% |
ESG Score
No data
About Celsius Holdings Inc
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...
Relevant Senate Committees
Oversees the FDA, which regulates food and beverage safety, labeling, and health claims. Celsius's 'clinically proven' and 'health benefits' claims place it directly under potential FDA scrutiny, making this committee highly relevant. Labor regulations also impact manufacturing costs.
This committee's oversight of the FTC is highly relevant, as the FTC directly regulates advertising, labeling, and health claims for consumer products like Celsius, especially concerning its 'clinically proven' and 'health benefits' statements.